feed,title,long_url,short_url
MarketWatch,Regeneron shares gain as the company launches Phase 3 trial for COVID-19 antibody treatment,http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/CgdidiPCByM/story.aspx,https://j.mp/2CcBc4t
